What to Expect at Your First Peptide Therapy Consultation

If you have spent time reading about peptide therapy, researching hormone optimization, or asking questions that your primary care provider did not have good answers to, you have likely reached the point where the next logical step is an actual conversation with a specialist. Knowing what a peptide therapy consultation looks like before you walk in, or before you join a telehealth call, makes that conversation significantly more productive. You arrive prepared, you ask the right questions, and you leave with a clearer picture of what is appropriate for your specific situation rather than a generic overview of what peptide therapy can do in general.

This guide walks through every stage of a peptide therapy consultation: what happens before, during, and after. It covers the questions a provider will ask, the lab work that is typically ordered, what you should be asking in return, and what the realistic outcomes of a first appointment look like. Understanding the process removes uncertainty, and for a category of medicine that involves prescription compounds, regulated pharmacies, and individualized medical assessment, that clarity matters.

Before the Peptide Therapy Consultation: What to Prepare

A peptide therapy consultation is a medical appointment, not a sales conversation. The quality of information you bring into it directly affects the quality of what you get out of it. Providers who specialize in hormone optimization and peptide therapy are working with limited time and are trying to form an accurate clinical picture of your situation. The more organized and specific you are, the faster they can get to useful conclusions.

Know Your Symptoms and When They Started

The most useful preparation for a peptide therapy consultation is a clear, specific account of what you are experiencing and when it started. Not “I feel tired a lot” but “I have had persistent fatigue for about two years, I wake around 3 AM and can’t fall back asleep, and my energy significantly dropped in my early 40s.” Specific, timed accounts help a provider identify whether what you are describing is consistent with hormonal axis decline, a thyroid issue, something metabolic, or something else entirely.

Write down the symptoms that bother you most. Include when they started, whether they are constant or intermittent, and whether any particular circumstances make them better or worse. Note any changes in sleep, energy, body composition, libido, mood, cognitive function, and recovery from exercise. These domains correspond directly to the axes a peptide therapy evaluation is designed to investigate.

Gather Your Previous Lab Work

If you have had any bloodwork in the past one to two years, bring it. Even a standard annual physical panel gives a provider useful baseline information. Particularly relevant are any testosterone, thyroid, or metabolic markers that were run. Even if those results were reported as normal, the provider may want to look at the actual values rather than just the flag status, because being within a reference range does not always mean being optimal for your age and symptom picture.

List All Current Medications and Supplements

This is non-negotiable. Several medications and even common supplements affect hormone levels, test results, and peptide safety profiles. Biotin, which is present in many hair, skin, and nail supplements, can interfere with immunoassay-based hormone tests at high doses. Thyroid medications interact with GHRH-stimulating peptides. Cardiovascular medications affect which peptides are appropriate. Testosterone, estrogen, or progesterone therapy you are already using changes the baseline picture entirely. Bring a complete list including doses.

Know What Questions You Want Answered

A peptide therapy consultation is also an opportunity for you to evaluate the provider. Prepare specific questions about the protocols they use, where compounds are sourced, how monitoring is handled, and what happens if you have side effects. A prepared patient who asks informed questions has a better consultation than one who is trying to absorb new information while also processing unfamiliar terminology.

During the Peptide Therapy Consultation: What the Provider Is Doing

A comprehensive peptide therapy consultation typically runs 45 to 60 minutes. The provider is not simply listening to your symptoms and matching them to a protocol. They are performing a differential evaluation: trying to determine what is actually driving what you are experiencing, whether peptide or hormone therapy is appropriate, if so which specific compounds are relevant, and what baseline markers need to be documented before any protocol begins.

The Medical History Review

The consultation will begin with a detailed medical history that goes considerably further than a typical GP appointment. Expect questions about your symptom history, health history, surgical history, family history for cancer and cardiovascular disease, and a thorough medication and supplement review. For men, the provider will want to know about urinary function and whether prostate health has been evaluated recently. For women, reproductive history, menstrual status, and any prior hormone therapy will be relevant.

A specific and important area of inquiry is cancer history. This is not alarmist. It is standard practice because several compounds used in peptide therapy, particularly GH-stimulating peptides like Sermorelin and Tesamorelin, involve the GH-IGF-1 axis, which requires a clean cancer history as a prerequisite. Any active malignancy is a contraindication. Past history may also affect the protocol design.

The Symptom Review

After medical history, the provider will typically go through a structured symptom review. This is where your prepared list is valuable. Energy levels and fatigue patterns, sleep architecture changes, body composition shifts, libido and sexual function, cognitive function and brain fog, mood and anxiety, recovery from exercise, and skin and hair changes are all relevant clinical data points that map to specific hormone axes. A thorough symptom review often reveals patterns that point toward specific pathways: consistent poor sleep with early waking and mood sensitivity suggests progesterone-related changes; central weight gain with fatigue and reduced libido in a male patient in his 50s suggests a testosterone axis evaluation is warranted; low energy with poor exercise recovery and reduced muscle maintenance across either sex points toward the GH-IGF-1 axis.

Laboratory Testing

In most peptide therapy consultations, the provider will not be able to design or recommend a specific protocol at the first appointment itself, because the baseline lab results are not yet available. What happens instead is that a comprehensive panel is ordered, drawn either at the appointment itself or at a nearby lab within the following few days, and the results are reviewed at a follow-up appointment or call.

The exact panel varies by provider and by what the clinical picture suggests, but a standard comprehensive evaluation typically includes the following markers. The full explanation of what each test is looking for and why it matters is covered in the companion article, What Labs Do You Need Before Starting Peptide Therapy.

The Discussion of Options

Even before lab results are back, a thorough first consultation will include an educational discussion of what the options are and how they work. This is where you learn whether the provider is proposing GH-axis support via peptide therapy, testosterone or estrogen replacement, a combination approach, or something more targeted based on your specific symptom picture. This is also when peptide-specific regulatory status is covered: which compounds are FDA-approved for what indications, which are available via licensed compounding pharmacies under a physician prescription, and which are not currently available for clinical use.

After the Peptide Therapy Consultation: What Happens Next

Once the lab results are back, typically within 3 to 7 business days, the provider reviews them and schedules a follow-up appointment or call. This is usually a shorter, more focused conversation: here is what your labs show, here is what that means for your specific situation, here is what protocol makes sense and why, and here is what monitoring will look like going forward.

Protocol Design

A well-designed peptide therapy protocol addresses specific, identified deficits confirmed by both labs and symptoms. It specifies which compound or compounds, the dose, the administration method and timing, and the monitoring schedule. It also includes a clear statement of what the protocol is expected to address and over what timeframe: IGF-1 response to a GH secretagogue is typically measurable at 3 months; body composition changes take longer; sleep changes may be among the earliest markers.

Pharmacy and Supply Chain

All compounds in a legitimate protocol come from licensed pharmacies. For FDA-approved biologics like Tesamorelin (EGRIFTA WR), this means a licensed pharmacy dispensing a finished pharmaceutical product. For compounded peptides like Sermorelin, it means a licensed 503A compounding pharmacy with a valid physician prescription. The provider should be able to tell you which pharmacy is being used and confirm it is a licensed, regulated facility. Compounds from unregulated online sources or labeled “research use only” are not equivalent and carry meaningful safety risks.

The Monitoring Schedule

A peptide therapy consultation is the beginning of an ongoing clinical relationship, not a one-time event. The monitoring schedule typically includes a safety check at 4 to 6 weeks, a full lab repeat at 3 months, and another at 6 months. Patients on testosterone therapy specifically require more frequent early monitoring because of hematocrit and PSA considerations. The provider should communicate clearly who is responsible for ordering and reviewing follow-up labs, and what the process is if you have questions or unexpected symptoms between scheduled appointments.

Questions to Ask During Your Peptide Therapy Consultation

Arriving with prepared questions is one of the most effective ways to ensure a productive peptide therapy consultation. These are the questions worth raising:

How to Tell If a Consultation Is the Right Fit

Not every provider offering peptide therapy consultations is operating to the same standard. Some things that signal a high-quality consultation: the provider orders baseline labs before prescribing, explains the regulatory status of proposed compounds without prompting, can name the pharmacy and confirm it is a licensed facility, discusses both what the therapy may help and what its limitations are, and gives you a clear monitoring schedule. They answer your questions directly and do not pressure you toward a decision at the first appointment.

Things that signal a lower-quality consultation: a protocol is proposed at the first appointment before labs are reviewed, compounds are offered that are on the FDA’s Category 2 prohibited list (such as BPC-157 or Semax), the pharmacy source is unspecified or described as “research-grade,” and monitoring is not discussed as part of the plan.

The best peptide therapy consultations feel like a genuine clinical evaluation, because that is what they are. For more on the category of compounds that are legally available and evidence-supported, the Complete Beginner’s Guide to Peptide Therapy covers the landscape clearly.